We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
- Authors
Hollenshead, Payton P.; Jackson, Corrie N.; Cross, Jordan V.; Witten, Taylor E.; Anwar, Ahmed I.; Ahmadzadeh, Shahab; Shekoohi, Sahar; Kaye, Alan D.
- Abstract
Infantile spasms, newly classified as infantile epileptic spasm syndrome (IESS), occur in children under 2 years of age and present as an occur as brief, symmetrical, contractions of the musculature of the neck, trunk, and extremities. When infantile spasms occur with a concomitant hypsarrhythmia on electroencephalogram (EEG) and developmental regression, it is known as West Syndrome. There is no universally accepted mainstay of treatment for this condition, but some options include synthetic adrenocorticotropic hormone (ACTH), repository corticotropin injection (RCI/Acthar Gel), corticosteroids, valproic acid, vigabatrin, and surgery. Without effective treatment, infantile spasms can cause an impairment of psychomotor development and/or cognitive and behavioral functions. The first-line treatment in the USA is ACTH related to high efficacy for cessation of infantile spasms long-term and low-cost profile. Acthar Gel is a repository corticotropin intramuscular injection that became FDA-approved for the treatment of IESS in 2010. Though it is believed that ACTH, Acthar Gel, and corticosteroids all work via a negative feedback pathway to decrease corticotropin-releasing hormone (CRH) release, their safety and efficacy profiles all vary. Vigabatrin and valproic acid are both anti-seizure medications that work by increasing GABA concentrations in the CNS and decreasing excitatory activity. Acthar Gel has been shown to have superior efficacy and a diminished side effect profile when compared with other treatment modalities.
- Subjects
UNITED States. Food &; Drug Administration; INFANTILE spasms; CORTICOTROPIN releasing hormone; ADRENOCORTICOTROPIC hormone; VALPROIC acid; INTRAMUSCULAR injections
- Publication
Neurological Sciences, 2024, Vol 45, Issue 2, p507
- ISSN
1590-1874
- Publication type
Article
- DOI
10.1007/s10072-023-07078-z